Lung transplantation for end-stage silicosis

Journal of Occupational and Environmental Medicine

Volumn 53, Issue 8, 2011, Pages 845-849

  Mao, Wen Jun ^a   Chen, Jing Yu ^a   Zheng, Ming Feng ^a   Ye, Shu Gao ^a   Liu, Feng ^a   He, Yi Jun ^a   Wu, Bo ^a   Zhang, Ji ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; GANCICLOVIR; ITRACONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; TACROLIMUS;

ADULT; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTINUOUS HEMODIAFILTRATION; DISEASE SEVERITY; END STAGE SILICOSIS; EXTRACORPOREAL OXYGENATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GRAFT RECIPIENT; HUMAN; INFECTION; INFECTION PREVENTION; KIDNEY FAILURE; LUNG TRANSPLANTATION; MALE; MULTIPLE ORGAN FAILURE; MYCOSIS; POSTOPERATIVE PERIOD; PRIMARY GRAFT DYSFUNCTION; QUALITY OF LIFE; RETROSPECTIVE STUDY; SILICOSIS; SURVIVAL;

EID: 80051792958     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0b013e3182260e50     Document Type: Article

References (22)

1. Christie JD, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report-2010. J Heart Lung Transplant. 2010;29:1104-1118.
2. Ding M, Chen F, Shi X, et al. Diseases caused by silica: mechanisms of injury and disease development. Int Immunopharmacol. 2002;2:173-182. (Pubitemid 34075408)
3. Leung CC, Chang KC, Law WS, et al. Determinants of spirometric abnormalities among silicoti patients in Hong Kong. Occup Med (Lond). 2005;55:490-493. (Pubitemid 41300663)
4. Hannaford-Turner K, Elder D, Sim MR, et al. Surveillance of Australian workplace Based Respiratory Events (SABRE) in New South Wales. Occup Med (Lond). 2010;60:376-382.
5. Campbell M, Thomas H, Hodges N, et al. A 24-year cohort study of mortality in slate workers in North Wales. Occup Med (Lond). 2005;5:448-453. (Pubitemid 41300656)
6. Mehnert WH, Staneczek W, Mohner M, et al. A mortality study of a cohort of slate quarry workers in the German Democratic Republic. IARC Sci Publ. 1990;97:55-64.
7. Chen G, Ma GX, Huang JH. Application of large volume whole lung lavage in pneumoconiosis. Chin J Ind Hyg Occup Dis. 2008;26:446-448.
8. Di Giuseppe M, Gambelli F, Hoyle GW, et al. Systemic inhibition of NF-kappaB activation protects from silicosis. PLoS One. 4:e5689. doi:10.1371/journal.pone.0005689.
9. Kreider M, Kotloff RM. Selection of candidates for lung transplantation. Proc Am Thorac Soc. 2009;6:20-27.
10. Davis SQ, Garrity ER Jr. Organ allocation in lung transplant. Chest. 2007;132:1646-1651. (Pubitemid 350156024)
11. Takahashi SM, Garrity ER Jr. The impact of the Lung Allocation Score. Semin Respir Crit Care Med. 2010;31:108-114.
12. Al-Githmi I, Batawil N, Shigemura N, et al. Bronchiolitis obliterans following lung transplantation. Eur J Cardiothorac Surg. 2006;30:846-851. (Pubitemid 44755355)
13. Hsu HH, Ko WJ, Chen JS, et al. Extracorporeal membrane oxygenation in pulmonary crisis and primary graft dysfunction. J Heart Lung Transplant. 2008;27:233-237.
14. Bittner HB, Binner C, Lehmann S, et al. Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplantation operations. Eur J Cardiothorac Surg. 2007;31:462-467. (Pubitemid 46329395)
15. Broomé M, Palmér K, Scherstén H, et al. Prolonged extracorporeal membrane oxygenation and circulatory support as bridge to lung transplant. Ann Thorac Surg. 2008;86:1357-1360.
16. Hsu HH, Ko WJ, Chen JS, et al. Extracorporeal membrane oxygenation in pulmonary crisis and primary graft dysfunction. J Heart Lung Transplant. 2008;27:233-237.
17. Mason DP, Boffa DJ, Murthy SC, et al. Extended use of extracorporeal membrane oxygenation after lung transplantation. J Thorac Cardiovasc Surg. 2006;132:954-960. (Pubitemid 44415877)
18. Oto T, Rosenfeldt F, Rowland M, et al. Extracorporeal membrane oxygenation after lung transplantation: evolving technique improves outcomes. Ann Thorac Surg. 2004;78:1230-1235. (Pubitemid 39303841)
19. Bermudez CA, Adusumilli PS. Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: long-term survival. Ann Thorac Surg. 2009;87:854-860.
20. Aigner C, Wisser W, Taghavi S, et al. Institutional experience with extracorporeal membrane oxygenation in lung transplantation. Euro J Cardiothorac Surg. 2007;31:468-474. (Pubitemid 46329394)
21. Christie JD, Kotloff RM, Ahya VN, et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med. 2005;171:1312-1316. (Pubitemid 40740741)
22. Fischer S, Bohn D, Rycus P, et al. Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: analysis of the Extracorporeal Life Support Organization (ELSO) registry. J Heart Lung Transplant. 2007;26:472-477. (Pubitemid 46602004)